Multimodality Imaging to Direct Management of Primary and Recurrent Rectal Adenocarcinoma Beyond the Total Mesorectal Excision Plane.

Autor:	Shur JD; From the Royal Marsden Hospital NHS Foundation Trust, Downs Road, Sutton SM2 5PT, England (J.D.S., S.Q., E.J., D.T., N.F., C.K., S.R., P.T., A.R., D.M.K.); and Institute of Cancer Research, Sutton, England (E.J., N.F., D.M.K.)., Qiu S; From the Royal Marsden Hospital NHS Foundation Trust, Downs Road, Sutton SM2 5PT, England (J.D.S., S.Q., E.J., D.T., N.F., C.K., S.R., P.T., A.R., D.M.K.); and Institute of Cancer Research, Sutton, England (E.J., N.F., D.M.K.)., Johnston E; From the Royal Marsden Hospital NHS Foundation Trust, Downs Road, Sutton SM2 5PT, England (J.D.S., S.Q., E.J., D.T., N.F., C.K., S.R., P.T., A.R., D.M.K.); and Institute of Cancer Research, Sutton, England (E.J., N.F., D.M.K.)., Tait D; From the Royal Marsden Hospital NHS Foundation Trust, Downs Road, Sutton SM2 5PT, England (J.D.S., S.Q., E.J., D.T., N.F., C.K., S.R., P.T., A.R., D.M.K.); and Institute of Cancer Research, Sutton, England (E.J., N.F., D.M.K.)., Fotiadis N; From the Royal Marsden Hospital NHS Foundation Trust, Downs Road, Sutton SM2 5PT, England (J.D.S., S.Q., E.J., D.T., N.F., C.K., S.R., P.T., A.R., D.M.K.); and Institute of Cancer Research, Sutton, England (E.J., N.F., D.M.K.)., Kontovounisios C; From the Royal Marsden Hospital NHS Foundation Trust, Downs Road, Sutton SM2 5PT, England (J.D.S., S.Q., E.J., D.T., N.F., C.K., S.R., P.T., A.R., D.M.K.); and Institute of Cancer Research, Sutton, England (E.J., N.F., D.M.K.)., Rasheed S; From the Royal Marsden Hospital NHS Foundation Trust, Downs Road, Sutton SM2 5PT, England (J.D.S., S.Q., E.J., D.T., N.F., C.K., S.R., P.T., A.R., D.M.K.); and Institute of Cancer Research, Sutton, England (E.J., N.F., D.M.K.)., Tekkis P; From the Royal Marsden Hospital NHS Foundation Trust, Downs Road, Sutton SM2 5PT, England (J.D.S., S.Q., E.J., D.T., N.F., C.K., S.R., P.T., A.R., D.M.K.); and Institute of Cancer Research, Sutton, England (E.J., N.F., D.M.K.)., Riddell A; From the Royal Marsden Hospital NHS Foundation Trust, Downs Road, Sutton SM2 5PT, England (J.D.S., S.Q., E.J., D.T., N.F., C.K., S.R., P.T., A.R., D.M.K.); and Institute of Cancer Research, Sutton, England (E.J., N.F., D.M.K.)., Koh DM; From the Royal Marsden Hospital NHS Foundation Trust, Downs Road, Sutton SM2 5PT, England (J.D.S., S.Q., E.J., D.T., N.F., C.K., S.R., P.T., A.R., D.M.K.); and Institute of Cancer Research, Sutton, England (E.J., N.F., D.M.K.).
Jazyk:	angličtina
Zdroj:	Radiology. Imaging cancer [Radiol Imaging Cancer] 2024 Mar; Vol. 6 (2), pp. e230077.
DOI:	10.1148/rycan.230077
Abstrakt:	Rectal tumors extending beyond the total mesorectal excision (TME) plane (beyond-TME) require particular multidisciplinary expertise and oncologic considerations when planning treatment. Imaging is used at all stages of the pathway, such as local tumor staging/restaging, creating an imaging-based "roadmap" to plan surgery for optimal tumor clearance, identifying treatment-related complications, which may be suitable for radiology-guided intervention, and to detect recurrent or metastatic disease, which may be suitable for radiology-guided ablative therapies. Beyond-TME and exenterative surgery have gained acceptance as potentially curative procedures for advanced tumors. Understanding the role, techniques, and pitfalls of current imaging techniques is important for both radiologists involved in the treatment of these patients and general radiologists who may encounter patients undergoing surveillance or patients presenting with surgical complications or intercurrent abdominal pathology. This review aims to outline the current and emerging roles of imaging in patients with beyond-TME and recurrent rectal malignancy, focusing on practical tips for image interpretation and surgical planning in the beyond-TME setting. Keywords: Abdomen/GI, Rectum, Oncology © RSNA, 2024.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu